Maze Therapeutics Corp (MAZE) Bozor kapitallashuvining balans qiymatiga nisbati

Maze Tx (MAZE) - korporativ logo

Maze Therapeutics Inc (MAZE) aksiyalarining narx dinamikasi Compass AI tizimi orqali aniq dori vositalarini ishlab chiquvchi va o'z narxini belgilash imkoniyatini ta'minlovchi kompaniya uchun ko'rsatkich bo'lib xizmat qiladi. Uning biotexnologiya sohasidagi vizioner sifatidagi maqomi investorlarning yuqori ishonchini tasdiqlaydi, bunda joriy ko'rsatkich 3.92 darajasida turibdi. Biznes katta ma'lumotlar to'plamini tahlil qilish uchun ta'minot zanjiri barqarorligini ta'minlash maqsadida havo transporti va kriogen komponentlarni saqlashga tayanadi.

Maze Therapeutics Corp (MAZE) Kapitallashuvning balans qiymatiga nisbati: 01.02.2025 - 30.10.2026 davri uchun

Maze Therapeutics, Inc. (MAZE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi Maze Therapeutics Inc|MAZE - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Maze Tx|MAZE - Biznes qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun sof aktivlar Maze Therapeutics|MAZE - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati mazetx.com|MAZE - Kompaniyaning umumiy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Maze Therapeutics Inc|MAZE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Maze Tx|MAZE - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Maze Tx|MAZE - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Maze Therapeutics|Tezkor likvidlik ko‘rsatkichi mazetx.com
- foyda va bozor multiplikatorlari tafsilotlari:
MAZE - Yakuniy foyda
Kompaniyaning dastlabki tahlili:Maze Therapeutics Inc, MAZE
Maze Therapeutics, Inc. ishlab chiqargan mahsulot

Maze Therapeutics Inc (MAZE) Compass platformasiga asoslangan maxsus genetik terapiya R&D tizimini ishlab chiqmoqda, bu esa raqobatchilar uchun fundamental kirish to'siqlarini yaratmoqda. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati koeffitsiyentidagi o'zgarishlarni tahlil qilish orqali investorlar bozorning kompaniya sof aktivlarini qanchalik hadda haddan tashqari yuqori baholayotganini baholashlari mumkin, bu esa ularga spekulyativ qizib ketishning joriy darajasini yoki emitentning intellektual va moddiy mulkining past baholanganini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

TEM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti qiagen.com (QGEN)|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM - Bozor qiymatining balans qiymatiga nisbati|Sarepta Therapeutics (SRPT) - Kapitallashuvning sof aktivlarga nisbati|TWST: Bozor kapitallashuvining balans qiymatiga nisbati|10x (TXG) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati NTLA|stoketherapeutics.com - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati BLFS|WVE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Sionna Pharma - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati PRME|TSHA: Kapitallashuvning sof aktivlarga nisbati|uniqure.com - Bozor kapitallashuvining balans qiymatiga multiplikatori|MGTX: Bozor kapitallashuvining balans qiymatiga nisbati|REGENXBIO Inc - Balans qiymatiga nisbatan bozor qiymati|SLDB (Solid Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Ocugen Pharma OCGN|Bozor qiymatining balans qiymatiga nisbati Pacific Biosciences (PACB)|BNTC (benitec.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati DSGN (Design Therapeutics, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Rocket Pharma RCKT|FDMT - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi LXEO|KRRO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti editasmedicine.com (EDIT)|Kapitallashuvning sof aktivlarga nisbati SLN|Bozor kapitallashuvining balans qiymatiga nisbati ProQR Therapeutics NV|Kapitallashuvning sof aktivlarga nisbati CDXS (Codexis, Inc.)|Bozor kapitallashuvining balans qiymatiga multiplikatori SGMO|Bozor kapitallashuvining balans qiymatiga nisbati NAUT (Nautilus Bio)|Balans qiymatiga nisbatan bozor kapitallashuvi metagenomi.co (MGX)|Precision BioSciences - Bozor kapitallashuvining balans qiymatiga nisbati|Generation Bio Co. (GBIO) - Kapitallashuvning sof aktivlarga nisbati|Boundless Bio, Inc (BOLD) - Bozor qiymatining balans qiymatiga nisbati|XCUR - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati IMNN|PHIO: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati MBIO|Balans qiymatiga nisbatan bozor kapitallashuvi transcodetherapeutics.com|Bozor qiymatining balans qiymatiga nisbati Bionano Genomics BNGO|APDN: Kapitallashuvning balans qiymatiga nisbati|bluebird bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|Omega Therapeutics, Inc. (OMGA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Singular Genomics Systems, Inc.|RGLS (Regulus Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Syros Pharmaceuticals, Inc|Kapitallashuvning sof aktivlarga nisbati TBIO (Telesis Bio, Inc.)|TCON: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)